Progression-free and overall survival in ALK-Positive NSCLC patients treated with sequential Crizotinib and Ceritinib

Justin F. Gainor, Daniel S W Tan, Tomasso De Pas, Benjamin J. Solomon, Aziah Ahmad, Chiara Lazzari, Filippo De Marinis, Gianluca Spitaleri, Katherine Schultz, Luc Friboulet, Beow Y. Yeap, Jeffrey A. Engelman, Alice T. Shaw

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Progression-free and overall survival in ALK-Positive NSCLC patients treated with sequential Crizotinib and Ceritinib'. Together they form a unique fingerprint.

Medicine & Life Sciences